Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20512127 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Omalizumab for Lupus
Conditions: Systemic Lupus Erthematosus;   Sjogren's Syndrome
Interventions: Drug: Omalizumab;   Drug: Placebo

Indicates status has not been verified in more than two years